Health ❯ Healthcare ❯ Cardiology
Risk Factors HFpEF Risks Treatment Options Innovative Treatments Artificial Intelligence Atrial Fibrillation Immune-Fibroblast Interaction Symptoms and Treatment Cardiac Regeneration Heart Transplantation Artificial Heart Transplant Surgery HfpEF Obesity Metrics Patient Outcomes Patient Management Treatment Guidelines Monitoring Devices Fluid Retention Indicators Dapagliflozin Mortality Rates GLP-1 Medications Inflammation Vericiguat Heart Failure Treatment AI in Cardiology Drug Treatments Preventive Measures Melatonin Use Hospitalization Arrhythmias Remote Monitoring Chronic Insomnia Quality of Life Management Strategies Warning Signs Social Determinants of Health Patient Education Symptoms Ejection Fraction Medication Adherence Cardiovascular Events Carotid Ultrasound Risk Assessment Patient Stories Risk Reduction Biventricular Heart Failure Reduced Ejection Fraction Clinical Trials Finerenone
Findings point to a strong signal in HFpEF, a hard-to-treat subtype, spurring calls for confirmatory trials.
